Suppr超能文献

肝细胞癌的遗传学分类。

Hepatocellular Carcinoma Genetic Classification.

机构信息

From the Division of Gastroenterology and Hepatology, University of Maryland School of Medicine.

Department of Medicine, University of Maryland Midtown Medical Center.

出版信息

Cancer J. 2023;29(5):249-258. doi: 10.1097/PPO.0000000000000682.

Abstract

Hepatocellular carcinoma (HCC) represents a significant global burden, with management complicated by its heterogeneity, varying presentation, and relative resistance to therapy. Recent advances in the understanding of the genetic, molecular, and immunological underpinnings of HCC have allowed a detailed classification of these tumors, with resultant implications for diagnosis, prognostication, and selection of appropriate treatments. Through the correlation of genomic features with histopathology and clinical outcomes, we are moving toward a comprehensive and unifying framework to guide our diagnostic and therapeutic approach to HCC.

摘要

肝细胞癌 (HCC) 是一种全球性的重大负担,其管理因肿瘤的异质性、不同表现和相对耐药性而变得复杂。近年来,人们对 HCC 的遗传、分子和免疫学基础有了更深入的了解,这使得对这些肿瘤进行详细分类成为可能,从而对诊断、预后和选择合适的治疗方法产生了影响。通过将基因组特征与组织病理学和临床结果相关联,我们正在朝着一个全面统一的框架发展,以指导我们对 HCC 的诊断和治疗方法。

相似文献

1
Hepatocellular Carcinoma Genetic Classification.
Cancer J. 2023;29(5):249-258. doi: 10.1097/PPO.0000000000000682.
2
Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy.
Gastroenterology. 2019 Jan;156(2):492-509. doi: 10.1053/j.gastro.2018.11.001. Epub 2018 Nov 4.
3
Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies.
J Hepatol. 2012 Jan;56(1):267-75. doi: 10.1016/j.jhep.2011.07.007. Epub 2011 Jul 23.
4
Integration of genomic information in the clinical management of HCC.
Best Pract Res Clin Gastroenterol. 2014 Oct;28(5):831-42. doi: 10.1016/j.bpg.2014.08.004. Epub 2014 Aug 23.
6
Fighting the bushfire in HCC trials.
J Hepatol. 2011 Aug;55(2):276-7. doi: 10.1016/j.jhep.2011.03.004. Epub 2011 Mar 22.
7
Rare variants of primary liver cancer: Fibrolamellar, combined, and sarcomatoid hepatocellular carcinomas.
Eur J Med Genet. 2021 Nov;64(11):104313. doi: 10.1016/j.ejmg.2021.104313. Epub 2021 Aug 18.
9
The advanced development of molecular targeted therapy for hepatocellular carcinoma.
Cancer Biol Med. 2022 Jun 15;19(6):802-17. doi: 10.20892/j.issn.2095-3941.2021.0661.
10
The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment.
Molecules. 2014 May 19;19(5):6393-406. doi: 10.3390/molecules19056393.

引用本文的文献

本文引用的文献

1
Hepatocellular carcinoma surveillance: current practice and future directions.
Hepatoma Res. 2022;8. doi: 10.20517/2394-5079.2021.131. Epub 2022 Mar 11.
2
Using quantitative immunohistochemistry in patients at high risk for hepatocellular cancer.
Genes Cancer. 2022 Jun 6;13:9-20. doi: 10.18632/genesandcancer.220. eCollection 2022.
3
Molecular pathogenesis and systemic therapies for hepatocellular carcinoma.
Nat Cancer. 2022 Apr;3(4):386-401. doi: 10.1038/s43018-022-00357-2. Epub 2022 Apr 28.
4
Unique molecular characteristics of NAFLD-associated liver cancer accentuate β-catenin/TNFRSF19-mediated immune evasion.
J Hepatol. 2022 Aug;77(2):410-423. doi: 10.1016/j.jhep.2022.03.015. Epub 2022 Mar 26.
5
Clinical Applications of Liquid Biopsy in Hepatocellular Carcinoma.
Front Oncol. 2022 Feb 8;12:781820. doi: 10.3389/fonc.2022.781820. eCollection 2022.
6
Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients.
PLoS One. 2022 Feb 14;17(2):e0263298. doi: 10.1371/journal.pone.0263298. eCollection 2022.
7
The Performance of AFP, AFP-3, DCP as Biomarkers for Detection of Hepatocellular Carcinoma (HCC): A Phase 3 Biomarker Study in the United States.
Clin Gastroenterol Hepatol. 2023 Feb;21(2):415-423.e4. doi: 10.1016/j.cgh.2022.01.047. Epub 2022 Feb 3.
8
β2-spectrin (SPTBN1) as a therapeutic target for diet-induced liver disease and preventing cancer development.
Sci Transl Med. 2021 Dec 15;13(624):eabk2267. doi: 10.1126/scitranslmed.abk2267.
9
Value of alpha-fetoprotein in hepatocellular carcinoma.
Transl Gastroenterol Hepatol. 2021 Oct 25;6:52. doi: 10.21037/tgh.2019.12.19. eCollection 2021.
10
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.
J Hepatol. 2022 Mar;76(3):681-693. doi: 10.1016/j.jhep.2021.11.018. Epub 2021 Nov 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验